Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
GO_Biological_Process_2023,Negative Regulation Of Execution Phase Of Apoptosis (GO:1900118),3/19,2.0661417263692345e-07,1.6529133810953876e-06,0,0,374.45625,5763.785131807041,MTRNR2L10;MTRNR2L12;MTRNR2L8
GO_Biological_Process_2023,Regulation Of Execution Phase Of Apoptosis (GO:1900117),3/24,4.307612149334254e-07,1.7230448597337017e-06,0,0,285.22857142857146,4180.798233078235,MTRNR2L10;MTRNR2L12;MTRNR2L8
GO_Biological_Process_2023,Negative Regulation Of Apoptotic Process (GO:0043066),3/482,0.0033224818255594,0.0083024358071997,0,0,12.217954070981213,69.72839215690162,MTRNR2L10;MTRNR2L12;MTRNR2L8
GO_Biological_Process_2023,Isoprenoid Biosynthetic Process (GO:0008299),1/8,0.0051890223794998,0.0083024358071997,0,0,237.8571428571429,1251.416370420653,IDI2
GO_Biological_Process_2023,Isoprenoid Metabolic Process (GO:0006720),1/8,0.0051890223794998,0.0083024358071997,0,0,237.8571428571429,1251.416370420653,IDI2
GO_Biological_Process_2023,Phospholipid Biosynthetic Process (GO:0008654),1/27,0.0174135879176465,0.0232181172235287,0,0,63.9775641025641,259.14140891073174,IDI2
GO_Biological_Process_2023,Phospholipid Metabolic Process (GO:0006644),1/69,0.0439459376578998,0.0451927319981768,0,0,24.41053921568627,76.2779330882361,IDI2
GO_Biological_Process_2023,Lipid Biosynthetic Process (GO:0008610),1/71,0.0451927319981768,0.0451927319981768,0,0,23.710714285714285,73.42779054088277,IDI2
